Specify a stock or a cryptocurrency in the search bar to get a summary
CeCors Inc
CEOSPsykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada. Address: 17 Belfield Road, Toronto, ON, Canada, M9W1E8
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CEOS
Dividend Analytics CEOS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CEOS
Stock Valuation CEOS
Financials CEOS
Results | 2019 | Dynamics |